NONOF - Madrigal climbs amid hopes for new NASH drug; B. Riley upgrades
2024-03-15 08:19:55 ET
More on Madrigal Pharmaceuticals
- Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown
- Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade)
- Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's Potential
- Biggest stock movers today: ADBE, GERN, and more
- Madrigal granted FDA approval for NASH therapy